Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depakote ER + Atypical Antipsychotic in Schizophrenia
NCT00073164Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of divalproex sodium in schizophrenia, sponsored by Abbott Laboratories. Started Jul 2003; status: completed.
02
Drugs
divalproex sodium
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00073164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073164.